Thesis (M.S.)--West Virginia University, 2001. / Title from document title page. Document formatted into pages; contains vi, 96 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references (p. 95).

Pantethine, a precursor of coenzyme A, has been shown to reduce serum cholesterol levels in hypercholesterolemic rabbits. The enzyme pantetheinase rapidly hydrolyzes pantethine to the vitamin pantothenic acid and the amino thiol cysteamine. This study was designed to compare the effect of cysteamine and pantothenate supplementation with that of pantethine on hypercholesterolemic rabbits. New Zealand white rabbits were fed a 0.5% cholesterol diet for 5 weeks; treatment groups received only the high cholesterol diet (control), or a high cholesterol diet supplemented with 1% pantethine, or an equimolar amount of pantothenic acid or cystamine (the disulfide of cysteamine). Blood samples were drawn weekly and total serum cholesterol levels analyzed enzymatically. Pantethine and cystamine both significantly reduced serum cholesterol levels (p < 0.05); pantothenic acid had no effect. Separation of serum lipoproteins using a preparative ultracentrifuge showed an increase in very low density, intermediate density and low density lipoproteins. A second experiment was conducted to compare the effect of cystamine with other small thiols; the protocol was similar to the first experiment with treatment groups consisting of a high cholesterol control, cystamine, cystine or 2,hydroxyethyl disulfide. There was no significant reduction in serum cholesterol levels between treatment groups, although the cystamine supplemented group tended to be lower than the other groups.

In 2007, a gene homolog of CDO encoded by the gene Gm237 in the DUF164 family was identified as cysteamine dioxygenase (ADO). ADO is one of the only known thiol dioxygenases found in mammals. Both ADO and its partner cysteine dioxygenase (CDO) are non-heme iron dependent enzymes that play a crucial role in the biosynthesis of taruine/hypotaurine by insertion of a dioxygen molecule. However, ADO has been overshadowed by CDO as heavy research focus on CDO over the past decade has led to the elucidation of its structure and possible mechanistic properties. In an effort to further understand ADO’s mechanism and regulating role in vivo, this work will be focused on the mammalian hADO and trying to gain further insight on hADO’s structural features via crystallography work. Investigation of the crystallization parameters for hADO has elucidated several potential conditions. Detailed work on these crystallization parameters will be presented.

No description available.

Cystinosis is a metabolic disorder characterised by the abnormal accumulation of the amino acid cystine in cells leading to a slow destruction of all major organs. If patients diagnosed with cystinosis are untreated, death due to kidney failure ensues in the second decade of life. A number of studies have shown the ability of the drug cysteamine (Cystagon®) to lower cystine accumulation within cells resulting in reduced organ and tissue damage. Cysteamine therapy however, is associated with a number of side effects involving the gastrointestinal tract and the central nervous system. Most of these arise due to the large amount of cysteamine present in the stomach and gut following administration. In addition, cysteamine possesses an unpleasant taste and smell, resulting in poor patient compliance. In an attempt to overcome these problems, a number of pro-drug derivatives of cysteamine and cystamine, the disulfide analogue of cysteamine, have been synthesised and evaluated. Pro-drugs were synthesised using a route established in our laboratories. Briefly, cystamine dihydrochloride was basified and allowed to react with a number of cyclic anhydrides under basic conditions. The resulting di-acids were reacted with carbonyldiimidazole and monoBoc-cystamine to yield the desired pro-drugs. Removal of the tBoc-protecting group was achieved in a facile manner by use of trifluoroacetic acid to yield product. The efficacy of the synthesised pro-drugs was determined by incubation of 50μM compound in a suspension of cultured cystinotic fibroblasts, with 50μM cysteamine as control. Cell growth was measured at 72 h and the level of thiol determined. All except one of the pro-drugs tested were significantly more effective than the control at lowering the cystine burden of the cells. Further work will concentrate on repeating these studies and evaluating a more robust Structure Activity Relationship for these compounds. The overall aim of all this work remains the production of an odourless, tasteless and orally active treatment for cystinosis and, if possible, improve on the current dosing regimen of every 6h. By using pro-drugs, cysteamine will be chemically camouflaged and hence, the side effects associated with its administration will be minimised or even entirely abolished.

Research on in vitro embryo production (IVP) in the equine is impeded by the limited availability of mature oocytes as the mare is mono ovulating and superovulation is still difficult (Dippert and Squires, 1994; Bezard et al., 1995; Alvarenga et al., 2001b). Despite recent improvement in IVM of equine oocytes, success rates of IVM in that species remain low in all culture media tested compared to other species (Goudet et al., 2000b). However, most studies have focused on the percentage of oocytes reaching the metaphase II stage (nuclear maturation) but few concentrated on the final oocyte competence as measured by its ability to develop into a blastocyst and further establish a pregnancy. Blastocyst production rate is influenced not only by culture environment but also by oocyte maturation conditions. Under in vitro culture conditions, oxidative modifications of cell components via increased ROS represent a major culture induced stress (Johnson and Nasr-Esfahani, 1994). Anti-oxidant systems can attenuate the deleterious effects of oxidative stress by scavenging ROS (Del Corso et al., 1994). Glutathione, a tripeptide thiol, is the major non-protein sulfydryl compound in mammalian cells that plays an important role in protecting the cell from oxidative damage (Meister and Tate, 1976; Meister and Anderson, 1983). It has been suggested that GSH content in oocytes may serve as a reservoir protecting the zygote and the early embryos from oxidative damage before genomic activation and de novo GSH synthesis occur (Furnus et al., 1998; de Matos and Furnus, 2000). The addition of GSH synthesis precursors, such as cysteamine, a thiol compound, to IVM media has been shown to improve IVP in various species (Takahashi et al., 1993; de Matos et al., 1995; Grupen et al., 1995; de Matos et al., 2002a; de Matos et al., 2002b; de Matos et al., 2003; Gasparrini et al., 2003; Oyamada and Fukui, 2004; Balasubramanian and Rho, 2007; Anand et al., 2008; Singhal et al., 2008; Zhou et al., 2008). Very little information on the use of thiol compounds in the equine is available. Conventional in vitro fertilization (IVF) has not been successful in the mare, and a repeatable IVF technique has not yet been developed (Alm et al., 2001). To overcome the limitation of conventional IVF procedures, other methods to produce embryos from oocytes, either in vivo or in vitro, have been investigated. Among these, intra cytoplasmic sperm injection (ICSI) has permitted efficient equine in vitro blastocyst production (Galli et al., 2002; Lazzari et al., 2002; Choi et al., 2006a; Choi et al., 2006c). However, ICSI requires specific equipment and skills. Transfer of an immature oocyte into the preovulatory follicle of an inseminated recipient mare (Intra-Follicular Oocyte Transfer, IFOT) has produced embryos but the success rate was low (Hinrichs and Digiorgio, 1991). Similarly, oocyte transfer (OT) into the oviduct of an inseminated recipient mare was investigated (McKinnon et al., 1988; Carnevale, 1996; Hinrichs et al., 1997; Carnevale et al., 2001; Carnevale et al., 2003; Carnevale, 2004), and commercial programs using OT for mares with reproductive abnormalities are now available (Carnevale et al., 2001). Unfortunately, IFOT is poorly documented in the literature and reports of OT have been published by various laboratories and under various conditions, making comparisons between results and choosing among these as substitutive techniques to ICSI or embryo transfer difficult. The first aim of the present work was to investigate if there is an influence of supplementation with 100 µM of cysteamine on conventional IVF success rate. Cumulus oocytes complexes (COCs) retrieved by transvaginal ultrasound guided aspiration were matured in vitro with or without cysteamine supplementation and were then submitted to conventional IVF using either calcium ionophore or heparin as capacitation treatment for spermatozoa. A total of 131 oocytes were evaluated for evidence of sperm penetration. Both techniques (ionophore or heparin) yielded 6% of IVF and results were similar both for the cysteamine and the control group. This success rate of IVF is low compared to some published data (Palmer et al., 1991; Dell'Aquila et al., 1996; McPartlin et al., 2009) but similar to what others reported in the literature (Choi et al., 1994; Dell'Aquila et al., 1997a). Although, it seems likely that cysteamine did not significantly improve IVF rates under our conditions, our general success rates for IVF procedures may be too low for us to conclude definitely about the effect of cysteamine. As ICSI was not available to us, the second aim of this work was to determine what in vivo technique could best bypass the lack of an efficient conventional IVF procedure. We compared embryo production following transfer of in vivo recovered oocytes (1) into a recipients oviduct or (2) into her preovulatory follicle either immediately after ovum pick up or (3) after in vitro maturation. Recipients were inseminated with fresh semen of a stallion with a known normal fertility. Ten days after transfer, rates of embryos collected in excess to the number of ovulations were calculated and compared for each group. Embryo collection rates were 32.5% (13/40), 5.5% (3/55) and 12.8% (6/47) for OT, post-IVM and immediate IFOT respectively. OT significantly yielded more embryos than immediate and post-IVM IFOT did. These results show that, when ICSI is not an option, intra-oviductal oocyte transfer is to be preferred to IFOT, as an in vivo alternative, to bypass the inadequacy of conventional in vitro fertilization and to assess oocyte developmental competence. After it was established that in comparison to IFOT, OT is the most reliable in vivo alternative to in vitro fertilization where ICSI technology is not available, this technique was used to assess the effect of cysteamine supplementation on nuclear maturation and oocyte competence. The third aim of this work was to investigate the influence of supplementation with 100 µM of cysteamine on in vitro nuclear and cytoplasmic maturation by specific DNA staining and the ability of oocytes to undergo in vivo fertilization after OT. Oocytes were collected by transvaginal ultrasound guided aspiration and matured in vitro with (cysteamine group) or without (control group) cysteamine. The nuclear stage after DNA Hoechst staining and the embryo yield following OT were used as a criterion for assessing nuclear and cytoplasmic maturation, respectively. Overall maturation rate was 52%, which is rates reported in the literature ranging from 40 to 70% in the equine (Goudet et al., 1997a; Bogh et al., 2002; Hinrichs et al., 2005; Galli et al., 2007). Nuclear maturation was not statistically different (p>0.05) between oocytes cultured with or without cysteamine (55% and 47% respectively). From 57 oocytes transferred to the oviduct in each group, the number of embryos collected was 10 (17%) in the control group and 5 in the cysteamine group (9%). Those two percentages were not statistically different (p>0.05). Contrary to the data described in other domestic species, there was no effect of cysteamine on in vitro nuclear maturation, or in vivo embryonic development under our conditions. Under our conditions, the addition of 100 µM of cysteamine to a classic culture medium does not improve equine oocyte maturation or embryonic development after OT. The same dose failed to increase GSH content in the equine (Luciano et al., 2006). However, the effect of cysteamine supplementation is highly species and concentration dependant. The inadequacy of the chosen concentration may explain that equine embryo production has not been increased by the cysteamine under our conditions as opposed to what has been observed in many other species. Alternatively, we can hypothesize that some substances present in the IVM medium can interfere with GSH synthesis. This has been suggested for FSH and estradiol (Bing et al., 2001) and, although our maturation medium is not supplemented with gonadotropins or estradiol, factors contained in fetal calf serum or EGF might also have an effect on GSH synthesis. Considering its beneficial effects in many other species, supplementation with cysteamine to different IVM media should be further investigated in the equine. Ideally combining different concentrations and ICSI or OT in order to determine an optimal concentration and its effects on oocyte developmental competence.

The function of the metalloenzymes is mainly determined by four structural features: the metal core, the metal binding motif, the second sphere residues in the active site and the electronic statistics. Cysteamine dioxygenase (ADO) and cysteine dioxygenase (CDO) are the only known enzymes that oxidize free thiol containing molecules in mammals by inserting of a dioxygen molecue. Both ADO and CDO are known as non-heme iron dependent enzymes with 3-His metal binding motif. However, the mechanistic understanding of both enzymes is obscure. The understanding of the mechanistic features of the two thiol dioxygenases is approached through spectroscopic and metal substitution in this dissertation. Another focus of the dissertation is the understanding of the function of a second sphere residue His228 in a 3-His-1-carboxyl zinc binding decarboxylase α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD). ACMSD catalyzes the decarboxylation through a hydrolase-like mechanism that is initialized by the deprotonation of metal bounded water molecule. Our study reveled that the second sphere residue His228 is responsible for the water deprotonation through hydrogen bonding. The spectroscopic and crystallographic data showed the H228Y mutation binds ferric iron instead of native zinc metal and the active site water is replaced by the Tyr228 residue ligation. Thus, we concluded that, H228Y not only plays a role of stabilizing and deprotonating the active site water but also is an essential residue on metal selectivity.

Advanced reproductive techniques use the 3 phase of in vitro production for bovine embryos, i.e. in vitro maturation (IVM), in vitro fertilization (IVF) and in vitro culture (IVC) as support for a variety of studies. This study assessed the effect of cysteamine, a thiol component, on the embryonic development during maturation, fertilization and in vitro culture. Bos taurus indicus Cumulus-oocyte complexes (COC) obtained from cow ovaries collected at a slaughterhouse were randomly distributed in four groups: controlgroup (without cysteamine, n=488), cysteamine in maturation (n=487), cysteamine in fertilization (n=489) and cysteamine in the culture medium (n=493). All COC were matured for 24h in TCM-199+0,01IUrFSH/mL+0,05mgLH/mL+10% fetal calf serum (FCS). In the cysteamine-maturation group, the TCM-199 medium was supplemented with 150μM cysteamine. The COC were matured at 38.5ºC with 5% of CO2 in air and humid atmosphere. The IVF (D0=fertilization day) was performed for 18-22h in Talp-Fert medium with heparin and PHE under the same conditions as IVM. The medium of the cysteamine-fertilization group was supplemented with 150μM cysteamine. For sperm capacitation, the semen was thawed, selected by percoll gradient and insemination was done with 2x106 spermatozoa/mL. Presumed zygotes from all groups were cultured in SOF + 5% FCS. In the cysteamine culture group the SOF medium was supplemented with 150μM cysteamine. Culture was maintained at 5%CO2, 5%O2, 90%N2 and saturated humidity for 8 days. Cleavage rates were 86, 89, 88 and 90 respectively, for control, maturation, fertilization and culture groups. Percentage of blastocyst on D7 were 29, 31, 38 e 35 and blastocyst hatched on D9 were 21, 23, 27 and 29, respectively. This study showed that adding cysteamine to the fertilization or culture medium improve the blastocyst production. Commercial OPU/IVP programs maybe benefit from the use of cysteamine. / As biotécnicas reprodutivas atuais utilizam como suporte para outros estudos a produção in vitro (PIV) de embriões bovinos, conduzida em três etapas igualmente importantes: maturação in vitro (MIV), fecundação in vitro (FIV) e cultivo in vitro (CIV). Nesta pesquisa avaliou-se o efeito da cisteamina, um componente thiol, nos meios de maturação, fecundação ou de cultivo sobre o desenvolvimento embrionário. Complexos cumulusoócitos (CCO=oócitos) coletados de ovários de vacas Bos taurus indicus provenientes de frigorífico foram selecionados e distribuídos aleatoriamente em quatro grupos: Grupo Controle (sem cisteamina, n=488), Cisteamina na maturação (n=487), Cisteamina na fecundação (n=489) e Cisteamina no cultivo (n=493). Os oócitos dos quatro grupos foram maturados por 24h em TCM-199 modificado acrescido de 0,01UI/mL rFSHh + 0,05mg/mL de LH e 10% de SFB. No grupo cisteamina-maturação, o meio TCM-199 foi suplementado com 150μM de cisteamina. Os oócitos foram maturados a 38,5ºC em estufa com 5%CO2 em ar e umidade saturada. A FIV (D0=dia da fecendação) foi realizada por 18-22 horas em meio Fert-Talp acrescido de heparina e PHE. Este meio utilizado no grupo cisteamina-fecundação foi adicionado de 150μM de cisteamina. Para capacitação, o sêmen foi descongelado e processado através do Gradiente de Percoll e a inseminação foi realizada com 2x106 espermatozóides/mL, nas mesmas condições atmosféricas da MIV. Os prováveis zigotos de todos grupos experimentais foram cultivados em meio SOF suplementado com 5% SFB. No grupo cisteamina-cultivo o meio SOF foi acrescido de 150μM de cisteamina. A atmosfera gasosa nos 8 dias de cultivo foi de 5% de CO2, 5% de O2 e 90% de N2 e umidade saturada. A clivagem foi de 86, 89, 88 e 90%, obtendo-se 29, 31, 38 e 35% de blastocistos em D7 e 21, 23, 27 e 29% de eclosão para os grupos controle, maturação, fecundação e cultivo, respectivamente. Em meio de fecundação (Fert-Talp) ou em meio de cultivo (SOFaaci) a cisteamina promove maior produção embrionária. O uso da cisteamina nos programas comerciais de OPU/PIV poderá contribuir para melhor eficiência da produção embrionária.

Au cours de ce travail nous avons étudié la réalisation de couches moléculaires d’accroche terminées amine. Sur l’oxyde de silicium l’aminopropyletriméthoxysilane (APTMS) a été déposé à partir d’une solution, et via une méthode originale par voie sèche qui nous a permis de mettre en évidence les temps caractéristiques de greffage et d’organisation de la couche d’APTMS. Sur l’or, les monocouches d’aminoéthanethiol (AET) et d’aminothiophénol (ATP) ont été réalisées à partir d’une solution. Nous avons ensuite étudié les aspects structuraux et cinétiques du greffage des fullerènes C60 sur de telles couches d’accroche, constituées de terminaisons amines soit sur toute la surface soit en des zones isolées (couches binaires). Les techniques de spectroscopie UV-Visible, IRTF, Raman, et XPS ont permis d’observer le greffage des C60 sur les couches aminées. La spectroscopie Raman en mode exalté (SERS) a mis en lumière que les molécules d’ATP étaient plus inclinées après le greffage à reflux des C60. Les analyses des diverses couches à l’échelle moléculaire ont été menées par microscopie à sondes locales (AFM, STM), et les mesures électriques réalisées sur or à l’aide de la pointe STM ont montré le caractère isolant de la couche d’accroche seule et un gap proche de celui du C60 après greffage des fullerènes. Elles ont également mis en évidence que le C60 était greffé sélectivement sur les zones terminées amines des couches d’accroche binaires. Enfin, une application potentielle des couches de C60 étant les mémoires moléculaires, les propriétés électriques des diverses couches réalisées ont été mesurées à l’aide de contacts électriques évaporés. / In this work we studied the preparation of sticking amine- terminated molecular layers. On silicon dioxide, 3-aminopropyltrimethoxysilane (APTMS) was de- posited from a solution, and using an original dry method that allowed us to determine time constants of APTMS layer grafting and organization. On gold surfaces, monolayers of aminoethanethiol (AET) and aminothiophenol (ATP) molecules were prepared from a solution. Then, we studied structural and kinetic aspects of ullerene C60 grafting on such sticking layers, terminated by amines either all over the surface or on isolated areas (binary layers). UV-visible, FTIR, Raman and XPS spectroscopy techniques enabled to observe that C60 was grafted on the amine-terminated layers. Exalted Raman spec- troscopy (SERS) revealed ATP molecules were more tilted after C60 grafting under reflux. Analyses of all the layers were made at a molecular level by local probe microscopy (AFM, STM), and electrical measurements performed on gold using the STM tip showed the in- sulating nature of the sticking layer whereas a gap close to that of C60 appeared after grafting of fullerenes. They also highlighted that C60 was selectively grafted on amine- terminated zones within binary sticking layers. At last, one of potential applications of C60 layers being molecular memory cells, electrical properties of the various studied layers were measured through evaporated electrical contact pads.

Le développement d’un médicament pour une cible thérapeutique donnée passe par plusieurs étapes qui se résument en une étape de criblage, une phase préclinique et plusieurs phases cliniques. Ces étapes permettent de sélectionner une substance active et de démontrer son efficacité thérapeutique et sa sécurité toxicologique. Ces deux critères définissent la qualité du médicament qui, une fois démontrée, doit être garantie pendant toute sa durée de validité. La qualité est évaluée au moyen d’études de stabilité qui sont réalisées d’abord sur la matière première de la substance active au cours de la phase de pré-développement du médicament, ensuite sur le produit fini. La stabilité intrinsèque de la substance active concerne à la fois ses propriétés chimiques et ses propriétés physiques qui sont liées à la nature de la substance. L’étude de stabilité repose d’abord sur la caractérisation de ces propriétés, et ensuite sur l’étude de la sensibilité de la substance à l’égard des facteurs environnementaux pouvant modifier les propriétés intrinsèques de la substance. L’approche adoptée dans ce travail repose d’une part sur l’évaluation de la stabilité chimique c’est à dire de la réactivité chimique des substances à usage pharmaceutique au travers des études de pureté chimique et des études de dégradation forcée de ces substances en solution, et d’autre part, sur l’évaluation de la stabilité physique. Dans ce cadre, l’étude du polymorphisme cristallin revêt une grande importance, tout comme l’aptitude à la formation d’hydrates ou de solvates. Cette étude, basée sur la thermodynamique, consiste pour l’essentiel à construire un diagramme de phases pression-température permettant de définir les domaines de stabilité relative des différentes formes cristallines. Cinq substances actives, existant à l’état solide et entrant dans la composition de médicaments administrés par voie orale, ont été étudiées dans le cadre de ce travail. L’analyse chimique du tienoxolol, présentant un effet anti-hypertenseur, a montré qu’il est très sensible à l’hydrolyse et à l’oxydation. Sept produits de dégradation ont été identifiés pour ce produit dont un schéma probable de fragmentation a été établi. Des diagrammes de phases pression-température ont été construits pour le bicalutamide et le finastéride, médicaments du cancer de prostate, en utilisant une approche topologique basée simplement sur les données disponibles dans la littérature. Cette étude a montré que la relation thermodynamique (énantiotropie ou monotropie) entre les formes cristallines sous conditions ordinaires peut être modifiée en fonction de la température et de la pression. Ce résultat est important pour la production des médicaments car il montre comment une telle information peut être obtenue par des mesures simples et accessibles aux laboratoires de recherche industrielle, sans que ces derniers soient contraints d’expérimenter sous pression. La méthode topologique de construction de diagramme de phases a été validée ensuite en la comparant à une méthode expérimentale consistant à suivre, par analyse thermique, des transitions de phases en fonction de la pression. La méthode expérimentale a été appliquée à deux composés, la benzocaine, anesthésique local, et le chlorhydrate de cystéamine, médicament utilisé pour les cystinoses. Les deux formes étudiées de benzocaine présentent une relation énantiotrope qui se transforme en relation monotrope à haute pression. Une nouvelle forme cristalline (forme III) du chlorhydrate de cystéamine a été découverte au cours de ce travail. La relation thermodynamique entre cette forme III et la forme I est énantiotrope dans tout le domaine de température et de pression. De plus, le chlorhydrate de cystéamine, classé hygroscopique, a fait l’objet d’une étude quantitative de sa sensibilité à l’eau, montrant qu’il devient déliquescent sans formation préalable d’hydrate (...) / The development of a drug for a given therapeutic target requires several steps, which can be summarized by drug screening, a preclinical phase and a number of clinical phases. These steps allow the selection of an active substance and a verification of its therapeutic efficacy and toxicological safety. The latter two criteria define the quality of the drug, which once demonstrated, must be guaranteed throughout its shelf life. Quality is assessed through stability studies that are carried out with the raw material of the active substance (preformulation phase) and with the final product. The intrinsic stability of the active substance depends on its chemical and physical properties and their characterization is the core of the stability studies, which in addition consists of sensitivity studies of the active pharmaceutical ingredient (API) for environmental factors that can modify the intrinsic properties of the substance. The approach presented in this work is based on the one hand on the assessment of the chemical stability, i.e. the reactivity of APIs through chemical purity studies and forced degradation in solution, and on the other hand on the assessment of the physical stability. For the latter, crystalline polymorphism is of great importance, as is the ability of the API to form hydrates or solvates. The study of crystalline polymorphism is based on the construction of pressure-temperature phase diagrams in accordance with thermodynamic requirements leading to the stability condition domains of the different crystalline forms. The stability behavior of five APIs used or meant for oral applications has been studied as part of this work. The chemical analysis of tienoxolol, an antihypertensive drug, has demonstrated its sensitivity for hydrolysis and oxidation. Seven degradation products were identified and patterns of fragmentation have been established. Pressure-temperature phase diagrams have been constructed for bicalutamide and finasteride, drugs against prostate cancer, using a topological approach based on data available in the literature. The study demonstrates that the thermodynamic relationship (enantiotropy or monotropy) between crystalline forms under ordinary conditions can change depending on the pressure. This is important for drug development as it demonstrates how stability information can be obtained by standard laboratory measurements accessible to industrial research laboratories without the necessity to carry out experiments under pressure. The topological approach for the construction of phase diagrams has subsequently been validated by measuring transition temperatures as a function of pressure. Experiments have been carried out with benzocaine, a local anesthetic, and with cysteamine hydrochloride, a drug used against cystinosis. Two crystalline forms were observed in the case of benzocaine. They exhibit an enantiotropic relationship that becomes monotropic at high pressure. For cysteamine hydrochloride, a new crystalline form (form III) was discovered. The thermodynamic relationship between the new form III and the known form I is enantiotropic for the entire temperature and pressure range. Cysteamine hydrochloride’s sensitivity to water has been studied, as it is hygroscopic. It has been demonstrated that it becomes deliquescent in the presence of water and no trace of a hydrate has been found. Finally, a study combining thermal and chromatographic methods showed that, under the effect of temperature, cysteamine hydrochloride turns into cystamine in the solid as well as in the liquid state, The latter is known to be an important impurity of cysteamine hydrochloride. In conclusion, the approach developed in this work allowed to characterize the stability properties of a number of APIs and to determine the factors that may change these properties and influence the intrinsic stability (...)